ROS1 and cancer: The results of the driver gene detection for EGFR, anaplastic lymphoma kinase (ALK), and C-ros oncogene1 receptor-tyrosine kinase (ROS1) in cancer cells from peripheral blood samples were negative (July 21, 2020).